%D9%85%D8%B1%D8%B6_%D8%A7%D9%84%D9%83%D8%A8%D8%AF_%D8%A7%D9%84%D8%AF%D9%87%D9%86%D9%8A_%D8%A7%D9%84%D9%84%D8%A7%D9%83%D8%AD%D9%88%D9%84%D9%8AYu-%C3%A7enq_x%C9%99st%C9%99liyiEsteatosi_hep%C3%A0tica_no_alcoh%C3%B2licaNon-alcoholic_fatty_liver_diseaseEsteatohepatitis_no_alcoh%C3%B3lica%D8%A8%DB%8C%D9%85%D8%A7%D8%B1%DB%8C_%DA%A9%D8%A8%D8%AF_%DA%86%D8%B1%D8%A8_%D8%BA%DB%8C%D8%B1_%D8%A7%D9%84%DA%A9%D9%84%DB%8CEi-alkoholiper%C3%A4inen_rasvamaksaSt%C3%A9atose_h%C3%A9patique_non_alcoolique%D7%9E%D7%97%D7%9C%D7%AA_%D7%94%D7%9B%D7%91%D7%93_%D7%94%D7%A9%D7%95%D7%9E%D7%A0%D7%99_%D7%A9%D7%90%D7%99%D7%A0%D7%94_%D7%A0%D7%95%D7%91%D7%A2%D7%AA_%D7%9E%D7%A6%D7%A8%D7%99%D7%9B%D7%AA_%D7%90%D7%9C%D7%9B%D7%95%D7%94%D7%95%D7%9CPenyakit_perlemakan_hati_non-alkoholik%E9%9D%9E%E3%82%A2%E3%83%AB%E3%82%B3%E3%83%BC%E3%83%AB%E6%80%A7%E8%84%82%E8%82%AA%E6%80%A7%E8%82%9D%E7%96%BE%E6%82%A3%D0%90%D1%80%D1%85%D0%B8%D0%BD%D1%8B_%D0%B1%D1%83%D1%81_%D0%B3%D0%B0%D1%80%D0%B0%D0%BB%D1%82%D0%B0%D0%B9_%D1%8D%D0%BB%D1%8D%D0%B3_%D3%A9%D3%A9%D1%85%D0%BB%D3%A9%D1%85_%D3%A9%D0%B2%D1%87%D0%B8%D0%BDPenyakit_hati_berlemak_bukan_alkoholNiet-alcoholische_steatohepatitisNiealkoholowa_st%C5%82uszczeniowa_choroba_w%C4%85trobyDoen%C3%A7a_hep%C3%A1tica_gordurosa_n%C3%A3o_alco%C3%B3lica%D0%9D%D0%B5%D0%B0%D0%BB%D0%BA%D0%BE%D0%B3%D0%BE%D0%BB%D1%8C%D0%BD%D0%B0%D1%8F_%D0%B6%D0%B8%D1%80%D0%BE%D0%B2%D0%B0%D1%8F_%D0%B1%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C_%D0%BF%D0%B5%D1%87%D0%B5%D0%BD%D0%B8Nealkoholna_ma%C5%A1%C4%8Dobna_jetrna_bolezen%E0%AE%AE%E0%AE%A4%E0%AF%81%E0%AE%9A%E0%AE%BE%E0%AE%B0%E0%AE%BE_%E0%AE%95%E0%AF%8A%E0%AE%B4%E0%AF%81%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%81%E0%AE%A8%E0%AE%BF%E0%AE%B1%E0%AF%88_%E0%AE%95%E0%AE%B2%E0%AF%8D%E0%AE%B2%E0%AF%80%E0%AE%B0%E0%AE%B2%E0%AF%8D_%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8DQ1546498
about
Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liver DiseaseA Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic SteatohepatitisTreatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin EAutonomic Dysfunction in Non-Alcoholic Fatty Liver DiseaseHepatic Dysfunction, Vitamin D Status, and Glycemic Control in DiabetesHydrogen-rich Water for Non-alchoholic Fatty Liver DiseaseOral Dietary Fucoxanthin Rich Supplement for Liver HealthSaroglitazar Magnesium 4 mg in the Treatment of NAFLD in Women With PCOS (EVIDENCES VII)Hepatic Metabolic Changes in Response to Glucagon InfusionEffect of Probiotic and Smectite Gel on NAFLDQuality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy VolunteersEarly Detection of Advanced Fatty Liver DiseaseStudy to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty LiverLiver Fibrosis in Peri-menopausal WomenA Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)Global Osteopathic Treatment for Patients With NAFLDEvaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver DiseaseInsulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control StudyRole of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver DiseaseA One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic SteatohepatitisNon Alcoholic Fatty Liver Disease Influence of Statin TherapyPrevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver BiopsyFatty Liver and Obstructive Sleep ApneaStudy of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic SteatohepatitisThe Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic SteatohepatitisColesevelam Versus Placebo in the Treatment of Nonalcoholic SteatohepatitisAdiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD)Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic SteatohepatitisResveratrol in Patients With Non-alcoholic Fatty Liver DiseaseSafety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) PatientsASSOCIATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND DIABETES MELLITUSEfficacy of Amlexanox vs. Placebo in Type 2 Diabetic PatientsGenetics of Fatty Liver Disease in ChildrenSitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver DiseaseEfficacy and Safety of Viusid in Patients With Nonalcoholic SteatohepatitisStudy of INT-747 in Patients With Diabetes and Presumed NAFLDTreatment of Nonalcoholic Fatty Liver Disease With Probiotics and PrebioticsA Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease
P1050
Nonalcoholic fatty liver disease and hepatocellular carcinomaMicronutrient Antioxidants and Nonalcoholic Fatty Liver DiseaseRole of bioactive fatty acids in nonalcoholic fatty liver diseaseThe Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular DiseaseRole of NLRP3 Inflammasome in the Progression of NAFLD to NASHRole of Hedgehog Signaling Pathway in NASHA Guide to Non-Alcoholic Fatty Liver Disease in Childhood and AdolescenceNAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic ManifestationsEffects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical TrialsThe Natural Course of Non-Alcoholic Fatty Liver DiseaseNovel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver HomeostasisRole of Serum Uric Acid and Ferritin in the Development and Progression of NAFLDUtilization of animal models to investigate non-alcoholic steatohepatitis-associated hepatocellular carcinomaNon-Alcoholic Fatty Liver Disease and Extra-Hepatic CancersGut Microbiota and Lifestyle Interventions in NAFLDVascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinNAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directionsNon-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver TransplantType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightDiet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetNAFLD and Chronic Kidney DiseaseTelomeres, NAFLD and Chronic Liver DiseaseMitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics ApproachGut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsExtracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver DiseaseBidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromeIon Channels and Oxidative Stress as a Potential Link for the Diagnosis or Treatment of Liver DiseasesGene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise reviewRelationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of EvaluationNutrition and Physical Activity in Nonalcoholic Fatty Liver DiseaseThe Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and ProgressionResearch advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisDoes Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-AnalysisRelevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver DiseaseNutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin ResistanceThe Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver DiseaseMedical nutrition therapy in non-alcoholic fatty liver disease--a review of literature
P921
Q61707455-94B94E43-3191-43EC-88EF-50735A087405Q61729735-D6AD6837-B567-4005-A53D-398CA37EF5EAQ61864829-14CA0002-6FD9-4C0D-9188-3E42CF049DAAQ61894216-D9BF14BF-1DD4-4A05-BA66-A8F9B217FCA3Q61894241-1F611D9C-62F6-4D4E-99D4-3C9C1E9D6B2FQ61902191-DCF7E49E-F927-447D-87CB-8737343B7F78Q61902201-65118EAC-0373-4177-8FDB-8625C380F377Q61904771-8460C8CA-9376-4660-BEAA-D59C7239D9CCQ61904912-D944D7C8-EB40-4188-9BDC-0710DAEC5AA7Q61905025-0C969C8C-609E-42C4-A6E5-B8546B289DD5Q61905069-7DED4CC4-8A42-4484-9B0C-1C1432474AA8Q61906833-45983AD2-0FFA-4CD7-9CE4-705058BD3D3CQ61907005-5286A6EF-E67D-4626-B38A-C746BC11DDEBQ61907440-ADCB913C-45FE-45E2-A444-06D722708287Q61907546-598D2081-508A-4D28-AF22-3F6070E7AC05Q61908971-F69CEFF6-9D72-4D94-8D96-EB3393EFE3B3Q61909549-221B8679-C215-44F8-B55C-E487BF70AD61Q61914818-D9E28C7A-EA16-4344-A072-D472A9F0CF3AQ61915225-046198C2-94F4-48B1-9A58-98436104412CQ61915615-C5FFB027-8494-4F37-9896-560D2D1A4BB7Q61917868-6CC985BD-CAA8-4B7E-A4DE-41C200408F2AQ61932349-16C1F9F0-A8D0-42AB-937C-A305C468F10EQ61936114-B4D00802-56FE-472C-A30A-786DF2609187Q61936668-69055858-5B8D-40A7-B558-E384D551F45DQ61936809-07FC28DB-5515-42C7-8A33-8B4873F09BEBQ61939040-5C1CDDDC-54E1-4F87-A687-58364FBD67C4Q61939264-A6261F9E-7552-401E-9EAD-2EF94A23BF37Q61955483-6A41C451-0F26-42D2-850D-04D088240360Q61956017-0A1F4733-C544-41E2-9DCD-4CABE2313931Q61956259-3687EAB6-708B-452C-8BEA-F7FC79677F43Q61956667-F8A51881-9D5C-4D15-83FA-65EFA43DC0B1Q61969395-11F239B9-6827-40B2-A3C9-E4753D2D25CCQ61969526-347950A3-9DB0-494F-B9CC-F9E32F01FBA6Q61974921-6CA25174-DEFC-4CCF-85B8-DFA793FDD1A1Q61975656-06531629-2EC5-4B9A-AB37-1CDB05D012BBQ61975890-4FFDFE32-62F5-4AAE-8B8A-120119B89035Q61979420-E012A626-5D5F-434B-9836-11BC873DB71AQ61980324-A18B1D41-39B8-4404-9F45-F29A9B16ADB5Q61980662-AFDCF175-A7D2-4E72-9CD2-55E06027E5FEQ61980672-915D91A8-F801-454C-B6C6-9C576984ED35
P1050
Q54814882-DE107B26-EA0A-44DD-83F9-A6BD7A339F01Q54814884-63683330-4BCA-4131-BBF2-1D58135D7C6BQ54814887-5076483F-31CE-40C6-A0C7-D7B1B63C7CBBQ54814890-A83968E3-12EB-4BA9-8140-FD32EE79A784Q54814895-9688C980-A199-43E3-8A73-B6054E974CFDQ54814896-C6C318B5-69F8-4825-91E4-306E190C9793Q54814908-72316C5A-BDA4-4407-B268-4DE9FD55E37EQ54814919-82BB7212-3390-4755-B3EC-C242F46293C6Q54814921-9F19EB5D-D1F5-4E74-AD3A-0E43F31062CDQ54814958-D179457B-5D13-4E25-BBA5-C6F827B97B65Q54814959-86E719F0-583F-48AC-86CA-DFC3125A838FQ54814979-C6DCADE3-BC14-4DF9-A8D9-E14C62F45F71Q54815007-DEE43E12-C799-4C30-AAF4-1709A2842594Q54815008-C8BA4FB0-C0AA-4C02-B987-1E4C85F1DEE6Q54815009-17AE98D0-0BE5-4B78-B3D2-E41073C2AFC4Q54815025-80F925E4-2DA1-4528-8356-96A41BBB1AF2Q54815027-7C97AECC-CC13-4964-B942-40DAD7D0152EQ54815028-9A721039-9BBA-420E-B160-B158E91FBAA2Q54815039-04A1A408-9BEB-4ECF-8B94-A1CD4BCD541EQ54815040-0522C680-269C-40B8-B2E9-F1C85A4E9EF0Q54815041-603C2241-4AD3-4C8B-A8EC-E9D78A391D9BQ54815045-62660627-E7D3-4096-A900-E2D6B299AAF0Q54815060-DC4B5252-3D86-4DD0-8BA4-7AEFC3E2ED48Q54815063-7A6E0D73-22EA-480B-B838-D0B487FAEC58Q54815065-AF36147A-8FBA-4801-B9E2-2CAB0B8379DAQ54815067-E7D607BD-CED4-4195-A9E1-4088264EE362Q54815068-D723DE0A-5C50-479B-851C-1EFA009995A8Q54815069-E301CA51-C3E8-47FC-AC64-86241E16718FQ54815072-DBAB1DBE-2AA3-482D-97F8-D7478C5EA278Q54815073-DFEE784A-8703-49CA-B4DC-4DE62FC7FCDEQ54815074-D124493F-A14B-4B7A-B76F-259DBCC67DEAQ54815075-DED1B678-5E1B-49BD-8FEE-172F4B6D17ADQ54815076-E26750D9-7509-4FC1-BB2A-0F372A59E186Q54815080-6023ED5E-E5FF-4CA6-9874-444AF412FE27Q54815082-76180537-EDF1-4E70-B729-8AF4EE3586D5Q54815083-D1CC02DC-5AAC-493F-B820-7E0BF93DCAEBQ54815088-E9F8954A-D173-4F83-90F7-A62C0E804379Q94207205-4F773B1A-4483-4EB3-B1BB-0B62DDA1BF0EQ94207209-191BE578-5868-48D1-8BF2-126ADF9D583B
P5166
Q21284740-90279B1F-87BF-4817-A31C-0894EA79123AQ26738646-071256A7-C75F-49F5-BC0B-CEE81AC73939Q26739904-10AF0703-6E94-42D8-B994-E129DF7F06D2Q26739993-721F0733-B863-4F91-88B5-99BD1ECA9072Q26742102-91C352E0-E0B3-40B7-9AEF-0D86BAAD1B35Q26743373-4F5F53DF-858C-4345-AD0C-C8DD876C00ABQ26744488-AD09C9E5-3BF8-49B4-A3A3-742B1AE0FEBDQ26745576-24085DB5-26B8-4849-A826-B2B35858B2C9Q26745869-57FA5F7C-D95B-449A-96FD-362441CF73EFQ26746947-D288935C-7381-40D1-A899-EB4AD7B0C7EFQ26746997-D5CAB237-B4D2-4FCE-986B-515D024599EAQ26748461-000F1B37-9C2A-4C15-A1CF-48995E3B30EFQ26748807-024C147D-8494-4F47-899E-3DF8E4774F5FQ26749045-9F4FB8D0-D4E7-4D97-887B-FAF44DEB673DQ26749783-DEED8778-F79A-47F3-8897-D3E512D0F869Q26750865-AAC539A3-864B-4DF3-B765-F54BA04161E3Q26750955-5E831B1C-CACC-4789-87D5-7B95E7128487Q26751258-173A4D82-24D9-48E4-9593-7F7E58495BA7Q26751404-11DC6101-0137-4AB1-9A4C-8A68A8B0988BQ26752583-58F4FDEE-2D67-405A-A1CA-0346E2637DF0Q26752614-4CD8B421-BDC4-4C26-86BD-808298244839Q26752759-A3BAD913-2FA0-4889-B06A-F20A2BB75095Q26753037-17836FED-1766-466A-A53C-A24401F173B6Q26753043-0C9CB29E-63DB-432E-9097-5AD4BC1E2BBFQ26753047-1A12FDDB-30F9-447F-A837-544F0EC00970Q26764843-EBB3E3E2-D244-4501-85D2-4BF3BC512A2EQ26765455-4F597C65-E105-489F-B35E-0C116109DD52Q26765808-F4A2F4D1-B325-4AFD-A78C-372B555ECC55Q26766459-E5804704-4B68-41CC-A81B-4F7F054BA10BQ26767276-A21E01EE-472E-4C30-A9A7-9A183FA5F3DDQ26771722-897BD110-867A-4B54-A935-5D1B625C66A0Q26771752-68E15406-0FD2-4074-BDD0-EA68F397A119Q26775025-62C5924F-3ED1-4432-8741-60DF207903DCQ26775340-0E25584B-B2B4-4A72-B438-7BD8107D058DQ26776043-BC7858F2-D4C6-47F2-BFED-19CBEC516B76Q26777980-E1870DBE-649A-4F26-806A-62E88F1DA02FQ26778020-57C9B051-2A7F-4A99-A259-A0A93EA2B63FQ26778135-F4BF3194-FF90-4AD3-BA3D-59E3D79052C4Q26780509-94608EC4-4172-47A1-8EAB-2C7AD6695816Q26782452-B512AEFF-2607-4116-827D-7CCD4790367F
P921
description
fatty liver disease characteri ...... ot caused by heavy alcohol use
@en
maladie du foie
@fr
zánětlivé onemocnění jater
@cs
name
Doença hepática gordurosa não alcoólica
@pt
Ei-alkoholiperäinen rasvamaksa
@fi
Esteatohepatitis no alcohólica
@es
Nealkoholická tuková jaterní choroba
@cs
Nealkoholna maščobna jetrna bolezen
@sl
Nichtalkoholische Fettleber
@de
Niealkoholowa stłuszczeniowa choroba wątroby
@pl
Niet-alcoholische steatohepatitis
@nl
Non-alcoholic fatty liver disease
@en
Penyakit hati berlemak bukan alkohol
@ms
type
label
Doença hepática gordurosa não alcoólica
@pt
Ei-alkoholiperäinen rasvamaksa
@fi
Esteatohepatitis no alcohólica
@es
Nealkoholická tuková jaterní choroba
@cs
Nealkoholna maščobna jetrna bolezen
@sl
Nichtalkoholische Fettleber
@de
Niealkoholowa stłuszczeniowa choroba wątroby
@pl
Niet-alcoholische steatohepatitis
@nl
Non-alcoholic fatty liver disease
@en
Penyakit hati berlemak bukan alkohol
@ms
altLabel
DHGNA
@pt
Doença hepática gordurosa não-alcoólica
@pt
EHNA
@ca
Esteato-hepatite não alcoólica
@pt
Esteatoepatite não-alcoólica
@pt
Esteatohepatite não-alcoólica
@pt
Esteatohepatitis no alcoholica
@es
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
@en
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1
@en
Fetge gras no alcohòlic
@ca
prefLabel
Doença hepática gordurosa não alcoólica
@pt
Ei-alkoholiperäinen rasvamaksa
@fi
Esteatohepatitis no alcohólica
@es
Nealkoholická tuková jaterní choroba
@cs
Nealkoholna maščobna jetrna bolezen
@sl
Nichtalkoholische Fettleber
@de
Niealkoholowa stłuszczeniowa choroba wątroby
@pl
Niet-alcoholische steatohepatitis
@nl
Non-alcoholic fatty liver disease
@en
Penyakit hati berlemak bukan alkohol
@ms
P2888
P492
P486
P6366
P646
P672
P1550
P1692
P1748
P1995
P2892
P31
P3417
Non-alcoholic-Fatty-Liver-Disease
P486
P5270
MONDO:0013209
P6366
2909145817
P646
P672
C06.552.241.519